IrAE

4 registered clinical trials studyying IrAE — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities NCT07381634	First Affiliated Hospital of Wenzhou Medical University	Phase 2
Not Yet Recruiting	Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer NCT07303881	The First Affiliated Hospital of Guangzhou Medical University	Phase 2
Recruiting	Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immu NCT06461780	Taipei Veterans General Hospital, Taiwan	N/A
Unknown	Thymosin Alpha-1 for irAE Secondary to ICIs NCT06178146	Jun Wang	Phase 4